Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $64.01 | $17.52 | 265.35% | 266.71x | 18.74x | 19.56x | 52.43x | 1.31x | $41.15M | 0.73% | $108.58M | 1.23 | $5.65B | 105.49 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $297.69 | $92.78 | 220.84% | 68.28x | 39.47x | 9.23x | 36.96x | 1.42x | $641.34M | 1.62% | $1.08B | 8.09 | $41.00B | 44.35 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.50 | $2.90 | 124.00% | 92.86x | 60.69x | 3.52x | 86.25x | 0.85x | $47.52M | 4.29% | $13.01M | 0.08 | $1.27B | 23.75 | ||
| CORT | CORCEPT THERAPEUTICS INC | $77.49 | $20.59 | 276.43% | 168.46x | 147.99x | 10.52x | 13.04x | 1.42x | $119.79M | 1.48% | $637.99M | 6.11 | $8.22B | -1,197.14 | ||
| KRYS | KRYSTAL BIOTECH INC | $309.75 | $94.64 | 227.31% | 39.97x | 38.96x | 21.74x | 7.15x | 1.91x | $237.38M | 2.62% | $1.28B | 43.59 | $8.64B | 40.38 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.48 | $70.78 | 0.99% | 24.15x | 8.62x | 5.60x | 38.60x | 0.43x | $667.65M | 7.91% | $219.64M | 1.86 | $10.31B | 16.53 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $48.70 | $17.19 | 183.38% | 49.69x | 38.15x | 4.94x | 6.19x | 1.35x | $164.23M | 4.41% | $605.69M | 7.92 | $3.57B | 31.99 | ||
| ASND | ASCENDIS PHARMA A | $213.23 | $80.06 | 166.33% | 22.60x | 14.30x | 13.00x | 23.07x | 2.31x | $52.94M | 0.40% | $574.09M | 9.24 | $13.63B | 146.10 | ||
| ADMA | ADMA BIOLOGICS INC | $8.12 | $9.61 | -15.53% | 11.77x | 8.88x | 3.76x | 4.82x | 0.45x | $107.90M | 5.63% | $390.33M | 1.65 | $1.94B | 8.77 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $13.66 | $15.84 | -13.77% | 6.66x | 28.49x | 6.52x | 3.92x | 0.89x | $56.42M | 7.07% | $205.80M | 3.52 | $713.06M | 4.93 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.91 | $41.45 | 39.70% | 41.36x | 15.27x | 3.44x | 1.80x | 0.57x | $767.06M | 6.88% | $6.21B | 32.27 | $9.55B | 19.80 | ||
| RPRX | ROYALTY PHARMA PLC | $55.63 | $39.57 | 40.59% | 29.13x | 10.43x | 9.96x | 3.22x | 0.63x | $2.34B | 9.63% | $9.94B | 22.75 | $40.40B | 34.73 | ||
| VCEL | VERICEL CORP | $37.03 | $9.06 | 308.51% | 86.12x | 76.81x | 6.44x | 5.31x | 1.81x | $47.49M | 2.52% | $356.23M | 7.02 | $1.88B | 46.42 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $229.19 | $49.01 | 367.60% | 487.64x | 8.91x | 3.20x | 3.17x | 1.64x | $1.30B | 9.15% | $4.53B | 73.22 | $17.94B | 26.57 | ||
| TGTX | TG THERAPEUTICS INC | $43.37 | $16.90 | 156.61% | 13.47x | 31.01x | 8.94x | 11.39x | 213.43x | -$14.19M | -0.23% | $583.13M | 4.04 | $6.95B | 46.31 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.10 | $35.47 | -3.85% | 13.48x | 9.27x | 2.19x | 2.17x | 0.51x | $341.79M | 17.33% | $910.35M | 15.75 | $1.54B | 6.51 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $243.28 | $93.64 | 159.79% | 30.79x | 26.80x | 17.62x | 4.89x | 1.55x | $122.22M | 2.53% | $997.32M | 50.16 | $5.21B | 23.11 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.57 | $5.69 | -54.83% | 9.52x | 3.76x | 2.41x | 2.81x | 0.20x | $7.24M | 4.90% | $52.93M | 0.92 | $95.15M | 6.14 | ||
| TECH | BIO-TECHNE CORP | $54.41 | $15.20 | 257.99% | 76.63x | 27.73x | 7.03x | 4.09x | 1.58x | $269.60M | 3.17% | $2.09B | 13.34 | $8.60B | 33.59 | ||
| UTHR | UNITED THERAPEUTICS CORP | $553.14 | $241.32 | 129.21% | 18.89x | 19.44x | 7.59x | 3.98x | 2.09x | $1.02B | 4.23% | $5.90B | 135.66 | $22.20B | 12.96 | ||
| EXEL | EXELIXIS INC | $52.99 | $30.60 | 73.16% | 16.98x | 16.09x | 5.76x | 6.88x | 1.24x | $917.69M | 6.70% | $1.94B | 7.49 | $13.26B | 12.56 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.51 | $2.44 | 43.84% | 14.63x | 14.84x | 2.15x | 3.40x | 0.99x | $4.11M | 1.45% | $82.33M | 1.03 | $215.58M | 10.15 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.34 | $12.15 | 157.92% | 17.31x | 15.98x | 6.42x | 3.79x | 3.89x | $208.13M | 5.43% | $1.01B | 8.28 | $3.08B | 9.20 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $445.77 | $166.61 | 167.56% | 26.21x | 22.80x | 9.27x | 5.84x | 1.91x | $3.71B | 3.28% | $19.36B | 76.20 | $109.63B | 20.33 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $616.18 | $432.56 | 42.45% | 14.48x | 13.10x | 4.30x | 2.06x | 0.98x | $4.11B | 6.42% | $31.42B | 302.15 | $64.34B | 11.20 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.98 | $1.25 | 58.37% | 10.42x | 9.12x | 2.07x | 2.37x | 2.57x | $13.00M | 8.23% | $67.23M | 0.84 | $126.30M | 5.66 | ||
| VCYT | VERACYTE INC | $49.24 | $7.54 | 553.02% | 44.36x | 44.15x | 7.23x | 2.92x | 9.45x | $155.34M | 3.97% | $1.34B | 16.90 | $3.70B | 32.19 | ||
| INCY | INCYTE CORP | $103.23 | $66.33 | 55.62% | 14.16x | 13.18x | 3.84x | 3.67x | 1.22x | $1.45B | 7.05% | $5.62B | 28.21 | $17.19B | 9.19 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $15.89 | $3.58 | 344.02% | 26.48x | 4.34x | 0.76x | 1.11x | 11.98x | $109.24M | 6.54% | $1.51B | 14.34 | $2.25B | 27.19 | ||
| MDXG | MIMEDX GROUP INC | $3.71 | $1.25 | 197.98% | 17.67x | -44.06x | 1.41x | 2.27x | 8.40x | $69.36M | 12.59% | $242.94M | 1.64 | $410.41M | 7.53 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.